{"transactions":[{"id":812520,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-04-08T23:33:34.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":2739,"price":20.448,"value":56007.072,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units."}],"balance_after":57022,"source":{"system":"sec-edgar","filing":"0000905148-26-001603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001603/form4.xml","form_type":"4"}},{"id":816329,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2026-04-03T21:57:35.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":false,"shares":5391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":5391,"derivative":{"underlying":"American Depositary Shares","underlying_shares":5391},"source":{"system":"sec-edgar","filing":"0000905148-26-001542","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001542/form4.xml","form_type":"4"}},{"id":816328,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2026-04-03T21:57:35.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":19523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":39046,"derivative":{"underlying":"American Depositary Shares","underlying_shares":19523},"source":{"system":"sec-edgar","filing":"0000905148-26-001542","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001542/form4.xml","form_type":"4"}},{"id":816327,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance-Based Share Units","published_at":"2026-04-03T21:57:35.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":14905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance-based share unit (\"PSU\") represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The reporting person was granted PSUs on March 12, 2025 based on the satisfaction of specified performance criteria between January 1, 2025 through December 31, 2025. On March 4, 2026, the performance-based vesting conditions were confirmed for PSUs representing 14,905 ADSs. The PSUs vest in full on March 12, 2028, the third anniversary of the date of grant, subject to continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The reporting person was granted PSUs on March 12, 2025 based on the satisfaction of specified performance criteria between January 1, 2025 through December 31, 2025. On March 4, 2026, the performance-based vesting conditions were confirmed for PSUs representing 14,905 ADSs. The PSUs vest in full on March 12, 2028, the third anniversary of the date of grant, subject to continuous service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":14905,"derivative":{"underlying":"American Depositary Shares","underlying_shares":14905},"source":{"system":"sec-edgar","filing":"0000905148-26-001542","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001542/form4.xml","form_type":"4"}},{"id":816326,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-04-03T21:57:35.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":9910,"price":20.39,"value":202064.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":59761,"source":{"system":"sec-edgar","filing":"0000905148-26-001542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001542/form4.xml","form_type":"4"}},{"id":816325,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-04-03T21:57:35.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":true,"shares":5391,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":69671,"source":{"system":"sec-edgar","filing":"0000905148-26-001542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001542/form4.xml","form_type":"4"}},{"id":816324,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-04-03T21:57:35.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":19523,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":64280,"source":{"system":"sec-edgar","filing":"0000905148-26-001542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001542/form4.xml","form_type":"4"}},{"id":841586,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2026-03-16T20:07:59.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":5323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":15971,"derivative":{"underlying":"American Depositary Shares","underlying_shares":5323},"source":{"system":"sec-edgar","filing":"0000905148-26-001283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001283/form4.xml","form_type":"4"}},{"id":841585,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2026-03-16T20:07:59.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":33783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in equal annual installments over four years beginning on 03/04/2027, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in equal annual installments over four years beginning on 03/04/2027, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":33783,"derivative":{"underlying":"American Depositary Shares","underlying_shares":33783},"source":{"system":"sec-edgar","filing":"0000905148-26-001283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001283/form4.xml","form_type":"4"}},{"id":841584,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-16T20:07:59.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":103950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in equal annual installments over four years beginning on 03/04/2027, the first anniversary of the date of grant, subject to continuous service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":103950,"derivative":{"exercise_price":19.27,"expiration_date":"2036-03-04","underlying":"American Depositary Shares","underlying_shares":103950},"source":{"system":"sec-edgar","filing":"0000905148-26-001283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001283/form4.xml","form_type":"4"}},{"id":841583,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-03-16T20:07:59.000Z","date":"2026-03-13","kind":"sale","planned":false,"acquired":false,"shares":2957,"price":18.628,"value":55082.996,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":44757,"source":{"system":"sec-edgar","filing":"0000905148-26-001283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001283/form4.xml","form_type":"4"}},{"id":841582,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-03-16T20:07:59.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":5323,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":47714,"source":{"system":"sec-edgar","filing":"0000905148-26-001283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001283/form4.xml","form_type":"4"}},{"id":858347,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-03-05T21:07:15.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":17.38,"value":173800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2025."}],"balance_after":42391,"source":{"system":"sec-edgar","filing":"0000905148-26-001174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826001174/form4.xml","form_type":"4"}},{"id":955181,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2026-01-02T21:15:40.000Z","date":"2025-12-30","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":42000,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000905148-26-000003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826000003/form4.xml","form_type":"4"}},{"id":955180,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-01-02T21:15:40.000Z","date":"2025-12-31","kind":"sale","planned":false,"acquired":false,"shares":10787,"price":17.432,"value":188038.984,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":52391,"source":{"system":"sec-edgar","filing":"0000905148-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826000003/form4.xml","form_type":"4"}},{"id":955179,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2026-01-02T21:15:40.000Z","date":"2025-12-30","kind":"exercise","planned":false,"acquired":true,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":63178,"source":{"system":"sec-edgar","filing":"0000905148-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514826000003/form4.xml","form_type":"4"}},{"id":1068902,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-08-12T20:45:52.000Z","date":"2025-08-08","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":35,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024."}],"balance_after":42178,"source":{"system":"sec-edgar","filing":"0000905148-25-002836","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825002836/form4.xml","form_type":"4"}},{"id":1176638,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2025-04-07T20:48:03.000Z","date":"2025-04-03","kind":"exercise","planned":false,"acquired":false,"shares":5391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":10782,"derivative":{"underlying":"American Depositary Shares","underlying_shares":5391},"source":{"system":"sec-edgar","filing":"0000905148-25-001113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825001113/form4.xml","form_type":"4"}},{"id":1176637,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-04-07T20:48:03.000Z","date":"2025-04-04","kind":"sale","planned":false,"acquired":false,"shares":3029,"price":33.108,"value":100284.132,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":45178,"source":{"system":"sec-edgar","filing":"0000905148-25-001113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825001113/form4.xml","form_type":"4"}},{"id":1176636,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-04-07T20:48:03.000Z","date":"2025-04-03","kind":"exercise","planned":false,"acquired":true,"shares":5391,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":48207,"source":{"system":"sec-edgar","filing":"0000905148-25-001113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825001113/form4.xml","form_type":"4"}},{"id":1179538,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2025-04-03T21:06:38.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":19523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":58569,"derivative":{"underlying":"American Depositary Shares","underlying_shares":19523},"source":{"system":"sec-edgar","filing":"0000905148-25-001078","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825001078/form4.xml","form_type":"4"}},{"id":1179537,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:06:38.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":7541,"price":35.894,"value":270676.654,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":42816,"source":{"system":"sec-edgar","filing":"0000905148-25-001078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825001078/form4.xml","form_type":"4"}},{"id":1179536,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-04-03T21:06:38.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":19523,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":50357,"source":{"system":"sec-edgar","filing":"0000905148-25-001078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825001078/form4.xml","form_type":"4"}},{"id":1197097,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-03-19T20:41:18.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":38.41,"value":115230.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024."}],"balance_after":30834,"source":{"system":"sec-edgar","filing":"0000905148-25-000969","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825000969/form4.xml","form_type":"4"}},{"id":1205682,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2025-03-14T21:14:05.000Z","date":"2025-03-12","kind":"grant","planned":false,"acquired":true,"shares":21294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Share Unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":21294,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21294},"source":{"system":"sec-edgar","filing":"0000905148-25-000922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825000922/form4.xml","form_type":"4"}},{"id":1205681,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-03-14T21:14:05.000Z","date":"2025-03-12","kind":"grant","planned":false,"acquired":true,"shares":65523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal annual installments over four years beginning on 03/12/2026, the first anniversary of the date of grant, subject to continuous service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":65523,"derivative":{"exercise_price":35.55,"expiration_date":"2035-03-12","underlying":"American Depositary Shares","underlying_shares":65523},"source":{"system":"sec-edgar","filing":"0000905148-25-000922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825000922/form4.xml","form_type":"4"}},{"id":1306671,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T19:17:50.000Z","date":"2025-01-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount, but less than $13.00 (any such option, an \"Underwater Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Underwater Option was not entitled to any payment of the Cash Amount in respect thereof and each Underwater Option was converted into the right to receive the CVR included in the Option Consideration  with respect to each Share underlying such Underwater Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (a) the total number of Shares underlying such Underwater Option, multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the amount of such milestone payment plus the amount of any other milestone payments that previously became due and payable under the terms of the CVR Agreement exceeds (2) the exercise price per Share with respect to such Underwater Option plus the Milestone Payment Amounts (as such term is defined in the CVR Agreement), [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, previously paid pursuant to the CVR Agreement in respect of each CVR granted in respect of such Underwater Option; provided further, that any Option with an exercise price that was equal to or greater than $13.00, was cancelled immediately prior to the effective time of the Merger without any payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":2.81,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":27350},"source":{"system":"sec-edgar","filing":"0001415889-25-001090","document":"form4-01082025_070147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000141588925001090/form4-01082025_070147.xml","form_type":"4"}},{"id":1306670,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T19:17:50.000Z","date":"2025-01-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount, but less than $13.00 (any such option, an \"Underwater Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Underwater Option was not entitled to any payment of the Cash Amount in respect thereof and each Underwater Option was converted into the right to receive the CVR included in the Option Consideration  with respect to each Share underlying such Underwater Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (a) the total number of Shares underlying such Underwater Option, multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the amount of such milestone payment plus the amount of any other milestone payments that previously became due and payable under the terms of the CVR Agreement exceeds (2) the exercise price per Share with respect to such Underwater Option plus the Milestone Payment Amounts (as such term is defined in the CVR Agreement), [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, previously paid pursuant to the CVR Agreement in respect of each CVR granted in respect of such Underwater Option; provided further, that any Option with an exercise price that was equal to or greater than $13.00, was cancelled immediately prior to the effective time of the Merger without any payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":2.76,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":55200},"source":{"system":"sec-edgar","filing":"0001415889-25-001090","document":"form4-01082025_070147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000141588925001090/form4-01082025_070147.xml","form_type":"4"}},{"id":1306669,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T19:17:50.000Z","date":"2025-01-08","kind":"other","planned":false,"acquired":false,"shares":58950,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 25, 2024, by and among Poseida Therapeutics, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Blue Giant Acquisition Corp., a wholly owned subsidiary of Parent (\"Merger Sub\").  On January 8, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $9.00 per Share in cash (the \"Cash Amount\"), and (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $4.00 per Share, [continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] in cash, upon the achievement of specified milestones, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\").  Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 25, 2024, by and among Poseida Therapeutics, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Blue Giant Acquisition Corp., a wholly owned subsidiary of Parent (\"Merger Sub\").  On January 8, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $9.00 per Share in cash (the \"Cash Amount\"), and (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $4.00 per Share, [continues to Footnote 2]"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"[continues from Footnote 1] in cash, upon the achievement of specified milestones, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\").  Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001090","document":"form4-01082025_070147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000141588925001090/form4-01082025_070147.xml","form_type":"4"}},{"id":1318629,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2025-01-02T21:13:44.000Z","date":"2024-12-30","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":63000,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000905148-25-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825000011/form4.xml","form_type":"4"}},{"id":1318628,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-01-02T21:13:44.000Z","date":"2024-12-31","kind":"sale","planned":false,"acquired":false,"shares":7583,"price":26.281,"value":199288.823,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F4","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":33834,"source":{"system":"sec-edgar","filing":"0000905148-25-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825000011/form4.xml","form_type":"4"}},{"id":1318627,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2025-01-02T21:13:44.000Z","date":"2024-12-30","kind":"exercise","planned":false,"acquired":true,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one ADS."}],"balance_after":41417,"source":{"system":"sec-edgar","filing":"0000905148-25-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514825000011/form4.xml","form_type":"4"}},{"id":1433616,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-08-14T20:18:54.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":3115,"price":16.2,"value":50463.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023."}],"balance_after":20417,"source":{"system":"sec-edgar","filing":"0000905148-24-002230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824002230/form4.xml","form_type":"4"}},{"id":1475315,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-18T20:12:15.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":27350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":27350,"derivative":{"exercise_price":2.81,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":27350},"source":{"system":"sec-edgar","filing":"0000950170-24-074862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000095017024074862/ownership.xml","form_type":"4"}},{"id":1475314,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:12:15.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":19650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":58950,"source":{"system":"sec-edgar","filing":"0000950170-24-074862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000095017024074862/ownership.xml","form_type":"4"}},{"id":1546664,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-04-05T21:47:15.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":false,"shares":5391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":16173,"derivative":{"underlying":"American Depositary Shares","underlying_shares":5391},"source":{"system":"sec-edgar","filing":"0000905148-24-001109","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824001109/form4.xml","form_type":"4"}},{"id":1546663,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-05T21:47:15.000Z","date":"2024-04-04","kind":"sale","planned":false,"acquired":false,"shares":1952,"price":15.673,"value":30593.696,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F3","text":"These ADSs were sold automatically to cover taxes upon vesting of RSUs."}],"balance_after":23532,"source":{"system":"sec-edgar","filing":"0000905148-24-001109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824001109/form4.xml","form_type":"4"}},{"id":1546662,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-04-05T21:47:15.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":true,"shares":5391,"price":15.9,"value":85716.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired upon vesting of Restricted Share Units (\"RSUs\")."}],"balance_after":25484,"source":{"system":"sec-edgar","filing":"0000905148-24-001109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824001109/form4.xml","form_type":"4"}},{"id":1549615,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-04-04T01:43:50.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":78092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Share Unit (\"RSU\") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each ADS represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":78092,"derivative":{"underlying":"American Depositary Shares","underlying_shares":78092},"source":{"system":"sec-edgar","filing":"0000905148-24-001090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824001090/form4.xml","form_type":"4"}},{"id":1549614,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-04-04T01:43:50.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":120141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Stock Option is exercisable for one American Depositary Share (\"ADS\"), which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each ADS represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":120141,"derivative":{"exercise_price":16.72,"expiration_date":"2034-04-01","underlying":"American Depositary Shares","underlying_shares":120141},"source":{"system":"sec-edgar","filing":"0000905148-24-001090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824001090/form4.xml","form_type":"4"}},{"id":1568708,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-03-19T20:12:55.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":2544,"price":18.86,"value":47979.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023."}],"balance_after":20093,"source":{"system":"sec-edgar","filing":"0000905148-24-000977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824000977/form4.xml","form_type":"4"}},{"id":1692467,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-01-04T00:26:06.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These Restricted Share Units vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These Restricted Share Units vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":84000,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000905148-24-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824000063/form4.xml","form_type":"4"}},{"id":1692466,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2024-01-04T00:26:06.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Restricted Share Units vested in full on 12/30/2023, the first anniversary of the date of grant. Vested shares were delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These Restricted Share Units vested in full on 12/30/2023, the first anniversary of the date of grant. Vested shares were delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":0,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000905148-24-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824000063/form4.xml","form_type":"4"}},{"id":1692465,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-01-04T00:26:06.000Z","date":"2024-01-02","kind":"sale","planned":false,"acquired":false,"shares":19363,"price":26.296,"value":509169.448,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F7","text":"These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units."}],"balance_after":22637,"source":{"system":"sec-edgar","filing":"0000905148-24-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824000063/form4.xml","form_type":"4"}},{"id":1692464,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-01-04T00:26:06.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":true,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."}],"balance_after":42000,"source":{"system":"sec-edgar","filing":"0000905148-24-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824000063/form4.xml","form_type":"4"}},{"id":1692463,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2024-01-04T00:26:06.000Z","date":"2023-12-29","kind":"exercise","planned":false,"acquired":true,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects a net reduction of 126,000 ADSs, which represents Restricted Share Units that were previously reported as aggregated with ADSs in Table I and are now separately reported in Table II."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0000905148-24-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000090514824000063/form4.xml","form_type":"4"}},{"id":1908307,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-02T20:14:25.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":55200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become exercisable in 36 equal monthly installments following May 1, 2023."}],"balance_after":55200,"derivative":{"exercise_price":2.76,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":55200},"source":{"system":"sec-edgar","filing":"0001209191-23-026474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000120919123026474/doc4.xml","form_type":"4"}},{"id":1908306,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:14:25.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":39300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares issuable upon the vesting of restricted stock units (\"RSUs\") granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest in three successive equal annual installments following May 1, 2023."}],"balance_after":39300,"source":{"system":"sec-edgar","filing":"0001209191-23-026474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000120919123026474/doc4.xml","form_type":"4"}},{"id":1925108,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Share Units","published_at":"2023-04-05T20:05:39.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":21564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":21564,"derivative":{"underlying":"American Depositary Shares","underlying_shares":21564},"source":{"system":"sec-edgar","filing":"0000899243-23-010711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000089924323010711/doc4.xml","form_type":"4"}},{"id":1925107,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-04-05T20:05:39.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":113217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Each ADS represents ten Ordinary Shares of the issuer."}],"balance_after":113217,"derivative":{"exercise_price":33.95,"expiration_date":"2033-04-03","underlying":"American Depositary Shares","underlying_shares":113217},"source":{"system":"sec-edgar","filing":"0000899243-23-010711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000089924323010711/doc4.xml","form_type":"4"}},{"id":2072620,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-03T21:10:15.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":183700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options vest in equal annual installments over five years beginning on 12/30/2023, the first anniversary of the date of grant."}],"balance_after":183700,"derivative":{"exercise_price":30.7,"expiration_date":"2032-12-30","underlying":"American Depositary Shares","underlying_shares":183700},"source":{"system":"sec-edgar","filing":"0000899243-23-000212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000089924323000212/doc4.xml","form_type":"4"}},{"id":2072619,"issuer":{"id":4271,"kind":"organization","name":"Zai Lab Ltd","symbol":"ZLAB"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares","published_at":"2023-01-03T21:10:15.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs."}],"balance_after":126000,"source":{"system":"sec-edgar","filing":"0000899243-23-000212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000089924323000212/doc4.xml","form_type":"4"}},{"id":2139195,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2022-10-11T20:35:42.000Z","date":"2022-10-07","kind":"tax_withholding","acquired":false,"shares":8464,"price":11.8265,"value":100099.496,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.7081 to $11.845, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":541946,"source":{"system":"sec-edgar","filing":"0001593968-22-001505","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000159396822001505/primary_01.xml","form_type":"4"}},{"id":2139194,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2022-10-11T20:35:42.000Z","date":"2022-10-07","kind":"grant","acquired":true,"shares":19120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance-based restricted stock units (Performance RSUs) granted on September 3, 2019. Performance RSUs vested upon the initiation of a Phase 2 clinical trial of ALLO-501A. Each Performance RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":550410,"source":{"system":"sec-edgar","filing":"0001593968-22-001505","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000159396822001505/primary_01.xml","form_type":"4"}},{"id":2142203,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"officer":true,"officer_title":"EVP of R&D"}}],"security":"Common Stock","published_at":"2022-10-05T20:02:55.000Z","date":"2022-10-03","kind":"tax_withholding","acquired":false,"shares":8968,"price":11.0617,"value":99201.3256,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.01 to $11.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1 share of the Issuer's common stock acquired by the reporting person on September 15, 2022 pursuant to an employee stock purchase program"}],"balance_after":531290,"source":{"system":"sec-edgar","filing":"0001593968-22-001495","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000159396822001495/primary_01.xml","form_type":"4"}},{"id":2197656,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2022-08-02T21:40:21.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":2000,"price":11.97,"value":23940.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022."}],"balance_after":540257,"source":{"system":"sec-edgar","filing":"0001737287-22-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000173728722000057/primary_doc.xml","form_type":"4"}},{"id":2211947,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2022-07-06T20:16:06.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":2000,"price":11.44,"value":22880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022."}],"balance_after":542257,"source":{"system":"sec-edgar","filing":"0001662119-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000166211922000002/primary_doc.xml","form_type":"4"}},{"id":2224125,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2022-06-22T20:47:41.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":2000,"price":11.18,"value":22360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022."}],"balance_after":544257,"source":{"system":"sec-edgar","filing":"0001214659-22-008241","document":"marketforms-56501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465922008241/marketforms-56501.xml","form_type":"4"}},{"id":2263711,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2022-05-19T21:40:15.000Z","date":"2022-05-19","kind":"sale","acquired":false,"shares":11500,"price":7.3993,"value":85091.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to 7.445, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 280 shares of the Issuer's common stock acquired by the reporting person on September 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":546257,"source":{"system":"sec-edgar","filing":"0001214659-22-007226","document":"marketforms-56248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465922007226/marketforms-56248.xml","form_type":"4"}},{"id":2317695,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T21:52:01.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":368589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter"}],"balance_after":368589,"derivative":{"exercise_price":9.69,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":368589},"source":{"system":"sec-edgar","filing":"0001214659-22-004375","document":"marketforms-55855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465922004375/marketforms-55855.xml","form_type":"4"}},{"id":2317694,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2022-03-25T21:52:01.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":237358,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":557477,"source":{"system":"sec-edgar","filing":"0001214659-22-004375","document":"marketforms-55855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465922004375/marketforms-55855.xml","form_type":"4"}},{"id":2327636,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2022-03-17T21:59:49.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":5169,"price":7.709,"value":39847.821,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.69 to $7.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1360 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program."}],"balance_after":320119,"source":{"system":"sec-edgar","filing":"0001214659-22-004087","document":"marketforms-55824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465922004087/marketforms-55824.xml","form_type":"4"}},{"id":2552046,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2021-10-04T21:55:37.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":11507,"price":24.3491,"value":280185.0937,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.17 to $24.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":323928,"source":{"system":"sec-edgar","filing":"0001214659-21-010210","document":"marketforms-53959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465921010210/marketforms-53959.xml","form_type":"4"}},{"id":2703176,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2021-05-20T21:22:58.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200534,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":335435,"source":{"system":"sec-edgar","filing":"0001214659-21-005769","document":"marketforms-52850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465921005769/marketforms-52850.xml","form_type":"4"}},{"id":2767994,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T20:47:54.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":92365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":92365,"derivative":{"exercise_price":33.78,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":92365},"source":{"system":"sec-edgar","filing":"0001214659-21-003598","document":"marketforms-52122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465921003598/marketforms-52122.xml","form_type":"4"}},{"id":2767993,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2021-03-30T20:47:54.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":24866,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":134901,"source":{"system":"sec-edgar","filing":"0001214659-21-003598","document":"marketforms-52122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465921003598/marketforms-52122.xml","form_type":"4"}},{"id":2782494,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2021-03-17T21:01:12.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":2798,"price":38.0524,"value":106470.6152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.975 to $38.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,156 shares of the Issuer's common stock acquired by the reporting person on March 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":110035,"source":{"system":"sec-edgar","filing":"0001214659-21-003241","document":"marketforms-51922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465921003241/marketforms-51922.xml","form_type":"4"}},{"id":3010044,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2020-10-08T21:10:43.000Z","date":"2020-10-07","kind":"sale","acquired":false,"shares":16538,"price":39.395,"value":651514.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in June 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":111677,"source":{"system":"sec-edgar","filing":"0001214659-20-008508","document":"marketforms-49847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465920008508/marketforms-49847.xml","form_type":"4"}},{"id":3016322,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2020-10-02T20:40:04.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":9752,"price":36.3681,"value":354661.7112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.  This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 863 and 1,142 shares of the Issuer's common stock acquired by the reporting person on March 13, 2020 and September 15, 2020, respectively, pursuant to an employee stock purchase program."}],"balance_after":128215,"source":{"system":"sec-edgar","filing":"0001214659-20-008375","document":"marketforms-49821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465920008375/marketforms-49821.xml","form_type":"4"}},{"id":3199373,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T20:37:16.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":109600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 13, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":109600,"derivative":{"exercise_price":18.22,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":109600},"source":{"system":"sec-edgar","filing":"0001214659-20-002804","document":"marketforms-48393.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465920002804/marketforms-48393.xml","form_type":"4"}},{"id":3199372,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2020-03-20T20:37:16.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":30800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":135962,"source":{"system":"sec-edgar","filing":"0001214659-20-002804","document":"marketforms-48393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465920002804/marketforms-48393.xml","form_type":"4"}},{"id":3421875,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-05T20:44:02.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":160630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":160630,"derivative":{"exercise_price":26.15,"expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":160630},"source":{"system":"sec-edgar","filing":"0001214659-19-005669","document":"marketforms-45677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465919005669/marketforms-45677.xml","form_type":"4"}},{"id":3421874,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of R&D and CMO"}}],"security":"Common Stock","published_at":"2019-09-05T20:44:02.000Z","date":"2019-09-03","kind":"grant","acquired":true,"shares":105162,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105162,"source":{"system":"sec-edgar","filing":"0001214659-19-005669","document":"marketforms-45677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000121465919005669/marketforms-45677.xml","form_type":"4"}},{"id":3444640,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2019-08-08T01:00:43.000Z","date":"2019-08-06","kind":"sale","acquired":false,"shares":11043,"price":2.06,"value":22748.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents six ordinary shares, nominal value GBP 0.001 per ordinary share, of the Issuer. The ADSs were obtained from the exercise of approximately 25% of an RSU-style share option covering ordinary shares of the Issuer granted on August 6, 2018 and which vested on August 6, 2019. Once vested, the RSU-style options must be exercised within a restricted period or they are forfeited. The exercise of the portion of these RSU-style share options and the sale reported in this Form 4 were effected pursuant to a Sell to Cover exercise implemented automatically in accordance with the Issuer's option plan, under which sufficient ADSs were sold by the Issuer to satisfy the Reporting Person's tax withholding obligations and associated sale costs. The residual ADSs are held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $2.02 to $2.085, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the ADSs sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The ADSs reported in this Column 5 represent solely those residual ADSs held by the Reporting Person which result from the Sell to Cover exercise transaction reported on this Form 4. Additionally, the Reporting Person holds 20,974 ADSs and RSU-style options and other options covering an aggregate of 9,356,928 ordinary shares of the Issuer."}],"balance_after":17237,"source":{"system":"sec-edgar","filing":"0001104659-19-044630","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465919044630/a4.xml","form_type":"4"}},{"id":3694581,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R & D"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2019-01-17T02:31:12.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":3028,"price":5.3694,"value":16258.5432,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents six ordinary shares, nominal value GBP 0.001 per ordinary share, of the Issuer. The ADSs were obtained from the exercise of approximately 25% of an RSU-style share option covering ordinary shares of the Issuer granted on January 12, 2018 and which vested on January 12, 2019. Once vested, the RSU-style options must be exercised within a restricted period or they are forfeited. The exercise of the portion of these RSU-style share options and the sale reported in this Form 4 were effected pursuant to a Sell to Cover exercise implemented automatically in accordance with the Issuer's option plan, under which sufficient ADSs were sold by the Issuer to satisfy the Reporting Person's tax withholding obligations and associated sale costs. The residual ADSs are held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $5.21 to $5.70, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the ADSs sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The ADSs reported in this Column 5 represent solely those residual ADSs held by the Reporting Person which result from the Sell to Cover exercise transaction reported on this Form 4. Additionally, the Reporting Person holds 16,000 ADSs and RSU-style options and other options covering an aggregate of 9,526,608 ordinary shares of the Issuer."}],"balance_after":4974,"source":{"system":"sec-edgar","filing":"0001104659-19-002164","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465919002164/a4.xml","form_type":"4"}},{"id":3700357,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R & D"}}],"security":"Option to purchase Ordinary Shares","published_at":"2019-01-09T02:01:07.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":224724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.26332 - GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 56,178 Ordinary Shares on January 4, 2020 and will be exercisable as to the remainder in annual installments of 56,178 Ordinary Shares on January 4, 2021 and January 4, 2022 and 56,190 Ordinary Shares on January 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable."}],"balance_after":224724,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":224724},"source":{"system":"sec-edgar","filing":"0001104659-19-001301","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465919001301/a4.xml","form_type":"4"}},{"id":3700356,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R & D"}}],"security":"Option to purchase Ordinary Shares","published_at":"2019-01-09T02:01:07.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":1006224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.70 based on an exchange rate of $U.S. 1.26332 - GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 251,556 Ordinary Shares on January 4, 2020 and will be exercisable as to the remainder in monthly installments of 20,958 Ordinary Shares on the fourth of each month from February 4, 2020 through December 4, 2022 and 21,138 Ordinary Shares on January 4, 2023."}],"balance_after":1006224,"derivative":{"exercise_price":0.89,"expiration_date":"2029-01-04","underlying":"Ordinary Shares","underlying_shares":1006224},"source":{"system":"sec-edgar","filing":"0001104659-19-001301","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465919001301/a4.xml","form_type":"4"}},{"id":3850853,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R & D"}}],"security":"Option to purchase Ordinary Shares","published_at":"2018-08-07T21:14:38.000Z","date":"2018-08-06","kind":"grant","acquired":true,"shares":678720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.29679 - GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 169,680 Ordinary Shares on August 6, 2019 and will be exercisable as to the remainder in annual installments of 169,680 Ordinary Shares on the sixth of each August from August 6, 2020 through August 6, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable."}],"balance_after":678720,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":678720},"source":{"system":"sec-edgar","filing":"0001104659-18-050188","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465918050188/a4.xml","form_type":"4"}},{"id":4097931,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2018-01-17T22:20:21.000Z","date":"2018-01-12","kind":"grant","acquired":true,"shares":192060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.3542 - GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 48,015 Ordinary Shares on January 12, 2019 and will be exercisable as to the remainder in annual installments of 48,015 Ordinary Shares on the twelfth of each January from January 12, 2020 through January 12, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable."}],"balance_after":192060,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":192060},"source":{"system":"sec-edgar","filing":"0001104659-18-002674","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465918002674/a4.xml","form_type":"4"}},{"id":4097930,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2018-01-17T22:20:21.000Z","date":"2018-01-12","kind":"grant","acquired":true,"shares":859968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.96 based on an exchange rate of $U.S. 1.3542 - GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 214,992 Ordinary Shares on January 12, 2019 and will be exercisable as to the remainder in monthly installments of 17,916 Ordinary Shares on the twelfth of each month from February 12, 2019 through January 12, 2022."}],"balance_after":859968,"derivative":{"exercise_price":1.3,"expiration_date":"2028-01-12","underlying":"Ordinary Shares","underlying_shares":859968},"source":{"system":"sec-edgar","filing":"0001104659-18-002674","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465918002674/a4.xml","form_type":"4"}},{"id":4488242,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":53247,"kind":"person","name":"Amado Rafael","position":1,"cik":"0001662119","reported_name":"Amado Rafael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2017-01-18T22:01:45.000Z","date":"2017-01-13","kind":"grant","acquired":true,"shares":2072976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.59 based on the closing midpoint exchange rate for the U.S. dollar on the day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 518,244 Ordinary Shares on January 13, 2018 and will be exercisable as to the remainder in monthly installments of 43,187 Ordinary Shares on the thirteenth of each month from February 13, 2018 through January 13, 2021."}],"balance_after":2072976,"derivative":{"exercise_price":0.72,"expiration_date":"2027-01-13","underlying":"Ordinary Shares","underlying_shares":2072976},"source":{"system":"sec-edgar","filing":"0001104659-17-002823","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662119/000110465917002823/a4.xml","form_type":"4"}}]}